An automated machine works on purification of drugs at the Gilead Sciences Inc. lab in Foster City, California, U.S. (Photographer: David Paul Morris/Bloomberg)

Patients Die as Breakthrough Cancer Drug Reaches Only a Few

(Bloomberg) -- Two months after Gilead Sciences Inc.’s breakthrough treatment was approved in the U.S. to treat a deadly form of blood cancer, only a tiny handful of patients have actually gotten t...

Bloomberg Quint

Add BloombergQuint App to Home screen.